LT4441B - Antigliukokortikoidinis vaistinis preparatas - Google Patents

Antigliukokortikoidinis vaistinis preparatas Download PDF

Info

Publication number
LT4441B
LT4441B LT98-054A LT98054A LT4441B LT 4441 B LT4441 B LT 4441B LT 98054 A LT98054 A LT 98054A LT 4441 B LT4441 B LT 4441B
Authority
LT
Lithuania
Prior art keywords
glucocorticoid
pheromones
steroidal
pheromone
preparation
Prior art date
Application number
LT98-054A
Other languages
English (en)
Lithuanian (lt)
Other versions
LT98054A (en
Inventor
Sergei Dmitrievich Burlakov
Dmitry Dmitrievich Genkin
Kirill Gennadievich Surkov
Viktor Veniaminovich Tets
Original Assignee
Sergei Dmitrievich Burlakov
Dmitry Dmitrievich Genkin
Kirill Gennadievich Surkov
Viktor Veniaminovich Tets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sergei Dmitrievich Burlakov, Dmitry Dmitrievich Genkin, Kirill Gennadievich Surkov, Viktor Veniaminovich Tets filed Critical Sergei Dmitrievich Burlakov
Publication of LT98054A publication Critical patent/LT98054A/xx
Publication of LT4441B publication Critical patent/LT4441B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Securing Of Glass Panes Or The Like (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
LT98-054A 1996-01-31 1998-04-21 Antigliukokortikoidinis vaistinis preparatas LT4441B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96101194/14A RU2125446C1 (ru) 1996-01-31 1996-01-31 Антиглюкокортикоидное лекарственное средство

Publications (2)

Publication Number Publication Date
LT98054A LT98054A (en) 1998-10-26
LT4441B true LT4441B (lt) 1999-01-25

Family

ID=20175968

Family Applications (1)

Application Number Title Priority Date Filing Date
LT98-054A LT4441B (lt) 1996-01-31 1998-04-21 Antigliukokortikoidinis vaistinis preparatas

Country Status (24)

Country Link
US (1) US5965623A (ko)
EP (1) EP0896819A4 (ko)
JP (1) JPH11504946A (ko)
KR (1) KR100347862B1 (ko)
CN (1) CN1213964A (ko)
AU (1) AU710479B2 (ko)
BG (1) BG102709A (ko)
BR (1) BR9612470A (ko)
CA (1) CA2244985A1 (ko)
CZ (1) CZ160598A3 (ko)
EE (1) EE9800209A (ko)
GE (1) GEP20001955B (ko)
HU (1) HUP9900504A2 (ko)
LT (1) LT4441B (ko)
LV (1) LV12177B (ko)
MD (1) MD1430B1 (ko)
MX (1) MX9806182A (ko)
NO (1) NO983508L (ko)
PL (1) PL187564B1 (ko)
RU (1) RU2125446C1 (ko)
SI (1) SI9620053A (ko)
SK (1) SK65598A3 (ko)
UA (1) UA48212C2 (ko)
WO (1) WO1997027845A1 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001039766A2 (en) * 1999-12-01 2001-06-07 Alydar Pharmaceuticals Ltd. Screening invertebrate pheromones for therapeutic activity
US6548706B2 (en) * 1999-12-23 2003-04-15 Aerojet Fine Chemicals Llc Preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl) -p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
US6806293B1 (en) 2001-03-12 2004-10-19 Darley Pharmaceuticals Ltd Use of pheromone compounds having MAP kinase modulating activity
EP1409656A4 (en) * 2001-03-12 2005-01-12 Darley Pharmaceuticals Ltd SCREENING OF PHEROMONAL COMPOUNDS OF NON-STEROID AND NON-PEPTIDE INVERTEBRATE HAVING ACTIVITY MODULATING MITOGEN-ACTIVATED PROTEIN KINASE
WO2003092614A2 (en) * 2002-05-02 2003-11-13 Hickle Randall S Lipid removal from the body
US6752649B2 (en) * 2002-11-07 2004-06-22 Xentris, Llc Illuminated indicia power supply apparatus and method of manufacture
DE10335845B4 (de) * 2003-05-09 2006-08-31 Müller, Martina, Dr.med. Pheromone als Antikrebsmittel
US20110195501A1 (en) * 2008-08-06 2011-08-11 Pangu Gautam D Ultrasonically induced release from polymer vesicles

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US161926A (en) 1875-04-13 Improvement in ink-wells
EP0331382A2 (en) 1988-02-29 1989-09-06 Pfizer Inc. Transdermal flux enhancing compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2900756A (en) * 1958-12-09 1959-08-25 Jacobson Martin Attractants for the gypsy moth
EP0149847A3 (en) * 1983-12-26 1989-11-08 Eisai Co., Ltd. Therapeutic and preventive agent containing dolichol
JPH0759504B2 (ja) * 1986-01-23 1995-06-28 エーザイ株式会社 ポリプレニルアルコ−ル含有注射剤
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
US4740627A (en) * 1987-05-21 1988-04-26 Phillips Petroleum Company Synthesis of E,Z-11-tetradecen-1-al
US5190978A (en) * 1989-09-29 1993-03-02 Dai-Ichi Kogyo Seiyaku Co. Ltd. Carcinostatic compositions and methods

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US161926A (en) 1875-04-13 Improvement in ink-wells
EP0331382A2 (en) 1988-02-29 1989-09-06 Pfizer Inc. Transdermal flux enhancing compositions

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
C. M. BAMBERGER, G. P. CHROUSOS: "The glucocorticoid receptor and RU 486 in man", ANN. N. Y. ACAD. SCI., 1995, pages 296 - 310
G. O. POTTS ET AL.: "Trilostane, an orally active inhibitor of steroid biosynthesis", STEROIDS, 1978, pages 257, XP023431039, DOI: doi:10.1016/0039-128X(78)90010-7
GOWER DB.: "Modifiers of steroid-hormone metabolism: a review of their chemistry, biochemistry and clinical applications", J STEROID BIOCHEM., 1974, pages 501 - 523, XP025197286, DOI: doi:10.1016/0022-4731(74)90051-X
H. J. KLOOSTERBOER ET AL.: "Pharmacological Properties of a New Selective Antiprogestagen: Org 33628", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1995, pages 192 - 201, XP008047334, DOI: doi:10.1111/j.1749-6632.1995.tb31379.x
OSORIO E CASTRO VR ET AL.: "Hemolysis of erythrocytes and fluorescence polarization changes elicited by peptide toxins, aliphatic alcohols, related glycols and benzylidene derivatives", BIOCHIM BIOPHYS ACTA., 1990, pages 252 - 258, XP023353608, DOI: doi:10.1016/0005-2736(90)90161-G
PRINGLE MJ, BROWN KB, MILLER KW.: "Can the lipid theories of anesthesia account for the cutoff in anesthetic potency in homologous series of alcohols?", MOL PHARMACOL., 1981, pages 49 - 55
SANDS J, AUPERIN D, SNIPES W.: "Extreme sensitivity of enveloped viruses, including herpes simplex, to long-chain unsaturated monoglycerides and alcohols", ANTIMICROB AGENTS CHEMOTHER, 1979, pages 67 - 73, XP009007372
SANDS JA, AUPERIN LD, REINHARDT A: "Enveloped virus inactivation by fatty acid derivatives", ANTIMICROB AGENTS CHEMOTHER, 1979, pages 134 - 136, XP009007053
V. P. GOLIKOB: "Receptornije mechanizmij gljukokortikoidnogo efekta"
W.L. DUAX, J.F. GRIFFIN, C.M. WEEKS, Z. WAWRZ: "The mechanism of action of steroid antagonists: Insights from crystallographic studies", JOURNAL OF STEROID BIOCHEMISTRY, 1988, pages 481 - 492, XP026069119, DOI: doi:10.1016/0022-4731(88)90002-7

Also Published As

Publication number Publication date
CA2244985A1 (en) 1997-08-07
NO983508D0 (no) 1998-07-30
EE9800209A (et) 1998-12-15
US5965623A (en) 1999-10-12
LT98054A (en) 1998-10-26
LV12177A (lv) 1998-12-20
KR100347862B1 (ko) 2003-01-24
CN1213964A (zh) 1999-04-14
PL187564B1 (pl) 2004-08-31
CZ160598A3 (cs) 1998-08-12
MD1430B1 (ro) 2000-03-31
PL322596A1 (en) 1998-02-02
BR9612470A (pt) 1999-07-13
JPH11504946A (ja) 1999-05-11
LV12177B (lv) 1999-06-20
NO983508L (no) 1998-07-30
BG102709A (en) 1999-06-30
RU2125446C1 (ru) 1999-01-27
GEP20001955B (en) 2000-03-05
EP0896819A1 (en) 1999-02-17
KR19990076946A (ko) 1999-10-25
HUP9900504A2 (en) 1999-09-28
UA48212C2 (uk) 2002-08-15
SK65598A3 (en) 1998-09-09
AU4636396A (en) 1997-08-22
WO1997027845A1 (fr) 1997-08-07
MX9806182A (es) 1998-10-31
AU710479B2 (en) 1999-09-23
SI9620053A (sl) 1998-04-30
EP0896819A4 (en) 2001-11-07

Similar Documents

Publication Publication Date Title
ES2617063T3 (es) Composición de vesículas lipídicas bifásicas y método para tratar la displasia de cuello uterino por suministro intravaginal
RU2560677C2 (ru) Кожная композиция, включающая аналог витамина d и смесь растворителя и поверхностно-активных веществ
JPH0478616B2 (ko)
PT1510213E (pt) Sistemas de melhoramento de penetração e reduzida irritação incluíndo testosterona
JP2002513749A (ja) 歯根療法へのゲル化できる医薬組成物の使用
EP2515866B1 (en) Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
LT4441B (lt) Antigliukokortikoidinis vaistinis preparatas
US6068860A (en) Pharmaceutical formulation
US20030199476A1 (en) Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof
DiPasquale et al. Modified granuloma pouch procedure for the evaluation of topically applied anti-inflammatory steroids
EP1700597A1 (en) Pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or a pharmaceutically acceptable salt thereof for cutaneous application
US20060247220A1 (en) Preventing the crystallization of cholesterol using oxysterols
JPH0912456A (ja) 薬物中毒疹用皮膚外用剤

Legal Events

Date Code Title Description
PC9A Transfer of patents

Owner name: "ASGL-RESEARCH LABORATORIES" J.S.C., RU

Effective date: 20030611

MM9A Lapsed patents

Effective date: 20050201